[Form 4] Life360, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Life360 director Chris Hulls received a grant of 26,499 restricted stock units (RSUs) that vest monthly over four years. Each RSU converts into one share upon settlement and 1/48th vests monthly beginning 09/01/2025, subject to continuous service. After the grant the reporting person beneficially owns 483,830 shares (including previously granted RSUs).

The filing discloses 151,934 previously granted RSUs, ownership through three family irrevocable trusts and a minority interest in ICCA Labs, LLC, and that 585,938 CDIs remain subject to a lock-up agreement.

Positive

• Grant of 26,499 RSUs provides additional equity stake for the reporting director
• Clear vesting schedule: 1/48th vests monthly from 09/01/2025, aligning vesting with continued service
• Beneficial ownership totaled 483,830 shares, showing substantial insider ownership disclosed

Negative

• RSUs represent potential future dilution upon settlement into common stock
• 585,938 CDIs remain subject to a lock-up agreement, limiting near‑term liquidity for that portion of holdings

Insights

Corporate Governance Expert

TL;DR: Director received time‑based equity that vests monthly over four years, increasing reported beneficial ownership but subject to standard vesting and lock-up conditions.

The grant of 26,499 RSUs is a routine equity compensation event for a director and is explicitly time‑based: 1/48th vests monthly from 09/01/2025, requiring continued service for settlement. The report aggregates beneficial ownership at 483,830 shares, which includes prior RSU grants and shares held indirectly via trusts and an LLC. The disclosure that 585,938 CDIs (converted on a 1:3 ratio) remain under lock-up is material to transferability and short‑term liquidity of those holdings. Overall, this filing documents compensation and ownership structure rather than operational or financial changes.

Securities Analyst

TL;DR: The transaction increases insider stake on paper but is time‑vested equity, so immediate market impact is limited; lock-up details constrain some shares.

From a market viewpoint, 26,499 RSUs add to the director’s long‑term equity exposure but carry no immediate share issuance until settlement. The filing clarifies composition of holdings, including 151,934 previously granted RSUs and indirect holdings via three irrevocable trusts and ICCA Labs, LLC. The reference to 585,938 CDIs under a lock‑up affects when a portion of shares may become tradable. This is primarily a governance/compensation disclosure with neutral near‑term price implications.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hulls Chris

(Last) (First) (Middle)

C/O LIFE360, INC.

1900 SOUTH NORFOLK STREET, SUITE 310

(Street)

SAN MATEO CA 94403

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Life360, Inc. [ LIF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/01/2025		A(1)		26,499	A	$0	483,830(2)(3)	D
Common Stock								195,312(4)	I	Held by the Robin Hulls 2023 Irrevocable Trust
Common Stock								195,312(4)	I	Held by the Rose Hulls 2023 Irrevocable Trust
Common Stock								195,312(4)	I	Held by the Mckenzie Hulls 2023 Irrevocable Trust
Common Stock								1,846(5)	I	Held by ICCA Labs, LLC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 1/48th of the RSUs will vest monthly from September 1, 2025, subject to the Reporting Person's continuous service through each vesting date.

2. Includes 151,934 RSUs previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

3. Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.

4. Represents shares of the Issuer's common stock underlying 585,938 CDIs, which remain subject to a lock-up agreement.

5. The Reporting Person is a member of ICCA Labs, LLC, an entity that holds an aggregate of 8,219 shares of the Issuer's common stock. The number of shares held as reported herein by the Reporting Person represents his proportionate ownership interest in ICCA Labs, LLC.

	/s/ Allison Chang, Attorney-in-Fact	09/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Life360 (LIF) director Chris Hulls report?

The reporting person was granted 26,499 restricted stock units (RSUs) on 09/01/2025; each RSU converts to one share upon settlement.

How do the RSUs vest for Chris Hulls in the Form 4?

Vesting is time‑based: 1/48th of the RSUs vests monthly beginning 09/01/2025, subject to continuous service through each vesting date.

How many shares does Chris Hulls beneficially own after the reported transaction?

The filing reports 483,830 shares beneficially owned following the reported transaction, which includes previously granted RSUs and other holdings.

Are any holdings subject to lock‑up or restrictions?

Yes: the filing states that shares underlying 585,938 CDIs remain subject to a lock‑up agreement.

Does the filing show indirect holdings for the reporting person?

Yes. The filing discloses indirect ownership via three irrevocable trusts (each holding 195,312 shares as reported) and a proportionate interest in ICCA Labs, LLC (1,846 shares reported).